cfDNA fragmentation patterns correlate with tumor burden measured via PSMA PET/CT volumetric parameters in patients with biochemical recurrence of prostate cancer

This prospective study demonstrated a statistically significant negative correlation between cfDNA fragmentation patterns and PSMA PET/CT volumetric parameters in patients with presumed localized prostate cancer with early biochemical recurrence. These findings underscore the potential of liquid biopsy as a biomarker and a complementary tool to PSMA PET/CT to assess disease progression during the follow-up of these patients.

Authors

Institutions

Publication Details

Journal
EJNMMI Research
Published
2024-12-18
DOI
https://doi.org/10.1186/s13550-024-01170-x
Citations
2
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.84
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

cfDNA fragmentation patterns correlate with tumor burden measured via PSMA PET/CT volumetric parameters in patients with biochemical recurrence of prostate cancer

Sergi Vidal‐Sicart, María J. Ribal, Joel Mases, Amparo Cobo et al.
2 citations
EJNMMI Research
Prostate Cancer Treatment and Research
0.84
article

cfDNA fragmentation patterns correlate with tumor burden measured via PSMA PET/CT volumetric parameters in patients with biochemical recurrence of prostate cancer

Sergi Vidal‐Sicart, María J. Ribal, Joel Mases, Amparo Cobo, Aida Niñerola, Inmaculada Romero‐Zayas, Pilar Paredes, Andrés Perissinotti, Xavier Setoaín, Katherine Quintero, Lourdes Mengual, Fiorella L. Roldán, Sebastián Casanueva-Eliceiry, Mercedes Ingelmo‐Torres, África Muxí, Laura Izquierdo, David Fuster, Antonio Alcaraz, Francisco Campos, Gary Amseian, Marcel Figueras, Mercè Moragas, Rita Pages, Rocío Caratini
article en
2 citations

Abstract

This prospective study demonstrated a statistically significant negative correlation between cfDNA fragmentation patterns and PSMA PET/CT volumetric parameters in patients with presumed localized prostate cancer with early biochemical recurrence. These findings underscore the potential of liquid biopsy as a biomarker and a complementary tool to PSMA PET/CT to assess disease progression during the follow-up of these patients.

EJNMMI ResearchVol. 14(1)
Hospital Clínic de Barcelona (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Universitat de Barcelona (ES)
Good health and well-being
Openalex Percentile: Top 22%
Prostate Cancer Treatment and Research
0.84
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.